Telesis Bio Announces 1-For-18 Reverse Stock Split, Will Open For Trading On The Nasdaq Global Select Market On May 9, 2024 On A Post-Split Basis
Telesis Bio Announces 1-For-18 Reverse Stock Split, Will Open For Trading On The Nasdaq Global Select Market On May 9, 2024 On A Post-Split Basis
Telesis Bio宣佈以1比18的比例進行反向股票拆分，將於2024年5月9日在納斯達克全球精選市場開放交易，分拆後將進行交易
Telesis Bio Inc. (the Company) (NASDAQ:TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced, flexible, and rapid automated synthesis in their own lab, today announced that it will effect a 1-for-18 reverse stock split of its common stock. The reverse stock split will take effect at 12:01 am (Eastern Time) on Thursday, May 9, 2024, and the Company's common stock will open for trading on The Nasdaq Global Select Market on May 9, 2024 on a post-split basis, under the existing ticker symbol "TBIO" but with a new CUSIP number 192003200. The reverse stock split...
Telesis Bio Inc.（以下簡稱 “公司”）（納斯達克股票代碼：TBIO）是RNA和DNA解決方案的領先提供商，使研究人員能夠在自己的實驗室中通過先進、靈活和快速的自動合成加快治療發現。該公...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。